NDLI: Dr. Google: what about the human papillomavirus vaccine?

Please wait, while we are loading the content...

HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey.

Addressing heterogeneous parental concerns about vaccination with a multiple-source model: a parent and educator perspective.

Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.

Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand.

Immunotherapeutic efficiency of a tetravalent Aß1-15 vaccine in APP/PS1 transgenic mice as mouse model for Alzheimer's disease.

The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines.

Effectiveness of seasonal influenza vaccine against clinically diagnosed influenza over 2 consecutive seasons in children in Guangzhou, China: a matched case-control study.

Public trust and vaccine acceptance--international perspectives.

Potential therapeutic anti-tumor effect of a Salmonella-based vaccine.

Impact of rotavirus vaccination in Australian children below 5 years of age: a database study.

The rise (and fall?) of parental vaccine hesitancy.

Dr. Google: what about the human papillomavirus vaccine?

Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine.

Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies.

Progress on the research and development of inactivated EV71 whole-virus vaccines.

Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children.

How society should respond to the risk of vaccine rejection.

Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.

Utilizing health information technology to improve vaccine communication and coverage.

Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine.

Validity of medical record documented varicella-zoster virus among unvaccinated cohorts.

Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV).

Story and science: how providers and parents can utilize storytelling to combat anti-vaccine misinformation.

Provider dismissal policies and clustering of vaccine-hesitant families: an agent-based modeling approach.

Immunogenicity and safety of three 2010–2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults: A double-blind and randomized trial

Negotiating vaccine acceptance in an era of reluctance.

Parental vaccine concerns, information source, and choice of alternative immunization schedules.

Overview: special focus vaccine acceptance.

Questionnaire for a biotech: NovaDigm Therapeutics.

Human Vaccines & Immunotherapeutics. Letter from the editor.

Year: 2013 Volume: 9 Issue: 7

Year: 2013 Volume: 9 Issue: 6

Year: 2013 Volume: 9 Issue: 5

Year: 2013 Volume: 9 Issue: 4

Year: 2013 Volume: 9 Issue: 3

Year: 2013 Volume: 9 Issue: 2

Year: 2013 Volume: 9 Issue: 1

Year: 2012 Volume: 8

Dr. Google: what about the human papillomavirus vaccine?

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Pías-Peleteiro, Leticia Cortés-Bordoy, Javier Martinón-Torres, Federico
Description	Country affiliation: Spain Author Affiliation: Pías-Peleteiro L ( Area of Pediatrics)
Abstract	OBJECTIVES: To assess and analyze the information and recommendations provided by Google Web Search™ (Google) in relation to web searches on the HPV vaccine, indications for females and males and possible adverse effects. RESULTS: In the comprehensive analysis of results, 72.2% of websites offer information favorable to HPV vaccination, with varying degrees of content detail, vs. 27.8% with highly dissuasive content in relation to HPV vaccination. The most frequent type of site is the blog or forum. The information found is frequently incomplete, poorly structured, and often lacking in updates, bibliography and adequate citations, as well as sound credibility criteria (scientific association accreditation and/or trust mark system). MATERIALS AND METHODS: Descriptive cross-sectional study of the results of 14 web searches. Comprehensive analysis of results based on general recommendation given (favorable/dissuasive), as well as compliance with pre-established criteria, namely design, content and credibility. Sub-analysis of results according to site category: general information, blog / forum and press. CONCLUSIONS: Google, as a tool which users employ to locate medical information and advice, is not specialized in providing information that is necessarily rigorous or valid from a scientific perspective. Search results and ranking based on Google's generalized algorithms can lead users to poorly grounded opinions and statements, which may impact HPV vaccination perception and subsequent decision making.
File Format	HTM / HTML
ISSN	21645515
e-ISSN	2164554X
DOI	10.4161/hv.25057
Journal	Human Vaccines & Immunotherapeutics
Issue Number	8
Volume Number	9
Language	English
Publisher	Taylor & Francis
Publisher Date	2013-08-01
Publisher Place	United States
Access Restriction	Open
Subject Keyword	Discipline Immunology Discipline Therapeutics Information Dissemination Papillomavirus Infections Prevention & Control Papillomavirus Vaccines Immunology Uterine Cervical Neoplasms Cross-sectional Studies Health Education Complications Epidemiology Etiology
Content Type	Text
Resource Type	Article
Subject	Immunology and Allergy Immunology Pharmacology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Human papilloma virus vaccines: need to be introduced in India.

Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece.

Human papillomavirus vaccine: a boon or curse.

Social media microblogs as an HPV vaccination forum.

The worldwide perspective on human papillomavirus and cervical cancer.

Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine?

HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey.

The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.

Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.

Dr. Google: what about the human papillomavirus vaccine?

Similar Documents

Human papilloma virus vaccines: need to be introduced in India.

Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece.

Human papillomavirus vaccine: a boon or curse.

Social media microblogs as an HPV vaccination forum.

The worldwide perspective on human papillomavirus and cervical cancer.

Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine?

HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey.

The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.

Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.

Dr. Google: what about the human papillomavirus vaccine?